Taken together, these results suggest that LRG1 can serve as a single-protein biomarker for distinguishing between patients with CRC and healthy donors, whereas LRG1+APOA4 constitutes a protein combination that can characterize disease status. The gene discussed is APOA4; the disease is colorectal carcinoma.